Associated Papers
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
Wei L et al.
Oncotarget, 2016
27823983 (PubMed )
Supplement: oncotarget-07-76374-s002.xlsx › 2
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.
Kurian MA et al.
The Lancet. Neurology, 2011
Select a paper to view details